Trade Mark Journal No.2026/011 13 March 2026

UK00004346602 27 February 2026 (9,42)

Image for mark UK00004346602 BIOPTIMUS
International priority date claimed: 25 February 2026 (European Union Intellectual Property Office (EUIPO)) (019321874)
Class 9
Downloadable computer software platforms for collecting, processing and analysing biological and scientific data for research; downloadable software for computational modelling and simulation of biological systems using multimodal data; downloadable computer software using artificial intelligence (AI) for data processing, data generation and data analysis; downloadable computer software using artificial intelligence (AI) for developing learning algorithms for data classification and decision support; downloadable software for simulation environments to test AI algorithms; downloadable computer software using artificial intelligence (AI) for conducting research in biology and life sciences; downloadable computer software using artificial intelligence (AI) for biological model development and for analysis and prediction in oncology, chemistry, biology, cosmetics, agroengineering, agrochemistry, longevity medicine and personalised medicine; downloadable software for deep learning, reinforcement learning, building neural networks, high performance computing, distributed computing, cloud computing, data analytics, mechanistic machine learning; downloadable application programming interface (API) for scientific modelling; downloadable software development kits (SDK); downloadable software for scientific modelling; downloadable software for scientific modelling, namely, artificial intelligence (AI) model weights; downloadable software using machine learning for tumour profiling and diagnostic modelling.
Class 42
Providing on-line non-downloadable software for collecting, processing, integrating and analysing biological and scientific data for research; research in the field of artificial intelligence (AI) technology; consultancy in the field of artificial intelligence; computer technology consultancy in the field of machine learning; technological consultation in the field of data analytics; research and development services in the field of engineering; providing on-line non-downloadable software for computational modelling and simulation of biological systems using multimodal data; providing on-line non-downloadable software for conducting research and tests in biology and life sciences using artificial intelligence (AI); biotechnology research; research and development services in the field of diagnostic preparations; computer programming consultancy; providing on-line non-downloadable software for biological model development and for data analysis and prediction in oncology, chemistry, biology, cosmetics, agroengineering, agrochemistry, longevity medicine and personalised medicine, using artificial intelligence (AI); providing on-line non-downloadable software for deep learning, reinforcement learning, building neural networks, high performance computing, distributed computing, cloud computing, data analytics, mechanistic machine learning; providing on-line non-downloadable software for modelling organic compounds and tumour profiling; providing on-line non-downloadable software for creation of machine learning diagnostic models; providing on-line non-downloadable software for analysis of genomic, proteomic and histology, pharmacokinetic, pharmacodynamics, clinical outcomes; medical and scientific research, namely, conducting clinical trials for others; providing on-line non-downloadable software for scientific modelling, namely, software development kits (SDK) and application programming interface (API).

BIOPTIMUS

Representative: Page, White & Farrer Limited